QuidelOrtho Corp (NAS:QDEL)
$ 44.18 2.07 (4.92%) Market Cap: 2.96 Bil Enterprise Value: 5.35 Bil PE Ratio: 0 PB Ratio: 0.89 GF Score: 78/100

QuidelOrtho Corp at Raymond James Institutional Investors Conference Transcript

Mar 05, 2024 / 09:00PM GMT
Release Date Price: $42.94 (-3.14%)
Andrew Harris Cooper
Raymond James & Associates, Inc., Research Division - Research Analyst

Great. Good afternoon, everyone. I'm Andrew Cooper, lead diagnostics analyst here at Raymond James. Pleased to be joined by the entire office of the CEO from QuidelOrtho to this morning. A lot going on, plenty to talk about here. So we're going to do a fireside chat. Like I said, the full team, happy to be joined on the stage by Mike Iskra, Interim CEO, Joe Busky, CFO; and Rob Bujarski, COO and President, I believe, now, right, as well as Juliet Cunningham in the audience who leads the IR efforts. Again, going to be a fireside chat. But maybe, Mike, just to start us off, can you take a few minutes, give some background on the company, the areas you play, the markets you play in, how you're positioned? And then some of what's going on maybe over the past couple of years in terms of COVID and all the moving parts there?

Michael S. Iskra
QuidelOrtho Corporation - Interim CEO, Executive VP & Chief Commercial Officer

Yes, I can take a moment. I can take the whole

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot